Articles dans des revues avec comité de lecture (173)
  1. 23. Beyer, I., Bautmans, I., Njemini, R., Demanet, C., Bergmann, P., & Mets, T. (2011). Effects on muscle performance of NSAID treatment with piroxicam versus placebo in geriatric patients with acute infection-induced inflammation. A double blind randomized controlled trial. BMC musculoskeletal disorders, 12, 292. doi:10.1186/1471-2474-12-292
  2. 24. Huyge, V., Garcia, C., Alexiou, J., Ameye, L., Vanderlinden, B., Lemort, M., Bergmann, P., Awada, A., Body, J.-J., & Flamen, P. (2010). Heterogeneity of metabolic response to systemic therapy in metastatic breast cancer patients. Clinical oncology, 22(10), 818-827. doi:10.1016/j.clon.2010.05.021
  3. 25. Mesquita, M., Demulder, A., Wolff, F., Melot, C., Damry, N., Dratwa, M., & Bergmann, P. (2010). Osteoprotegerin and progression of coronary and aortic calcifications in chronic kidney disease. Transplantation proceedings, 42(9), 3444-3449. doi:10.1016/j.transproceed.2010.09.129
  4. 26. Devogelaer, J.-P., Reginster, J.-Y., Rompen, E., Boutsen, Y., Body, J.-J., Bergmann, P., Rozenberg, S., Gaspard, U., Herion, F., & Reychler, H. (2010). L'ostéonécrose maxillaire associée aux traitements aux bisphosphonates dans le traitement de l'ostéoporose. Consensus interdisciplinaire. Louvain médical, 129(8), 305-309.
  5. 27. Body, J.-J., Bergmann, P., Boonen, S., Boutsen, Y., Devogelaer, J.-P., Goemaere, S., Kaufman, J.-M., Rozenberg, S., & Reginster, J.-Y. (2010). Evidence-based guidelines for the pharmacological treatment of postmenopausal osteoporosis: a consensus document by the Belgian Bone Club. Osteoporosis international, 21(10), 1657-1680. doi:10.1007/s00198-010-1223-4
  6. 28. Ghys, C., Ramon, I., Moreau, M., Paesmans, M., Bergmann, P., Rozenberg, S., Peretz, A., Dekelver, C., Karmali, R., & Body, J.-J. (2010). Distribution of clinical risk factors for fracture in a Brussels cohort: implications for fracture risk assessment on osteoporosis management in clinical practice. Osteoporosis international, 21(1), 209.
  7. 29. Ramon, I., Jelloul, E., Moreau, M., Paesmans, M., Rozenberg, S., Bergmann, P., Peretz, A., Dekelver, C., Karmali, R., & Body, J.-J. (2010). The impact of fracture risk assessment on osteoporosis management in clinical practice in a Brussels cohort. Osteoporosis international, 21(1), 209.
  8. 30. Bergmann, P., Karmali, R., & De Wolf, N. (2010). Does PTHrP plays a role in the stimulatory effect of strontium on osteoblast like cells UMR 106.1 mineralization ? Journal of bone and mineral research, 25(Supplément S1), MO0197, 419. doi:10.1002/jbmr.5650251305
  9. 31. Bergmann, P., Body, J.-J., Boonen, S., Boutsen, Y., Devogelaer, J.-P., Goemaere, S., Kaufman, J.-M., Reginster, J.-Y., & Rozenberg, S. (2010). Loading and skeletal development and maintenance. Journal of osteoporosis, 2011, 786752. doi:10.4061/2011/786752
  10. 32. Brachet, C., Boros, E., Tenoutasse, S., Lissens, W., Andry, G., Martin, P., Bergmann, P., & Heinrichs, C. (2009). Association of parathyroid adenoma and familial hypocalciuric hypercalcaemia in a teenager. European journal of endocrinology, 161(1), 207-210. doi:10.1530/EJE-09-0257
  11. 33. Bergmann, P., Body, J.-J., Boonen, S., Boutsen, Y., Devogelaer, J.-P., Goemaere, S., Kaufman, J.-M., Reginster, J.-Y., & Gangji, V. (2009). Evidence-based guidelines for the use of biochemical markers of bone turnover in the selection and monitoring of bisphonate treatment in osteoporosis: a consensus document of the Belgian Bone Club. International journal of clinical practice, 63(1), 19-26. doi:10.1111/j.1742-1241.2008.01911.x
  12. 34. Matrane, A., Mariaule, E., Martin, P., & Bergmann, P. (2009). Hémorragie digestive basse: Apport de la scintigraphie aux hématies marquées. Revue médicale de Bruxelles, 30(1), 55-58.
    13. << Précédent 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 Suivant >>